NIM
IMCR icon

NEOS Investment Management’s Immunocore IMCR Stock Holding History

NEOS Investment Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,599
Closed -$784K – 614
2025
Q4 		$784K Buy
22,599
+1,229
+6% +$43.4K ﹤0.01% 572
2025
Q3 		$776K Sell
21,370
-836
-4% -$28.4K 0.01% 545
2025
Q2 		$697K Buy
22,206
+6,778
+44% +$211K 0.01% 505
2025
Q1 		$458K Buy
15,428
+4,234
+38% +$127K 0.01% 522
2024
Q4 		$330K Buy
11,194
+1,102
+11% +$34.8K 0.01% 549
2024
Q3 		$314K Buy
10,092
+638
+7% +$23.2K 0.01% 538
2024
Q2 		$320K Buy
9,454
+5,510
+140% +$281K 0.01% 513
2024
Q1 		$256K Buy
3,944
+116
+3% +$7.96K 0.02% 511
2023
Q4 		$262K Buy
+3,828
New +$199K 0.02% 431

Other funds holding IMCR

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

NEOS Investment Management's IMCR Position: Q1 2026 in Review

NEOS Investment Management sold out of Immunocore (IMCR) in Q1 2026, closing a stake of 22,599 shares — an estimated $784K sold.

NEOS Investment Management first reported a position in IMCR in Q4 2023 and held it in 9 quarters. The position peaked at $784K in Q4 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • NEOS Investment Management reported no remaining Immunocore position as of Q1 2026 after selling out during the quarter.
  • NEOS Investment Management sold 22,599 Immunocore shares in Q1 2026, an estimated $784K.
  • NEOS Investment Management first reported a position in Immunocore in Q4 2023 and held it in 9 quarters.
  • NEOS Investment Management's Immunocore position peaked at $784K in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.